| Product Code: ETC9946070 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Herpes Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Herpes Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Herpes Market - Industry Life Cycle |
3.4 United Kingdom (UK) Herpes Market - Porter's Five Forces |
3.5 United Kingdom (UK) Herpes Market Revenues & Volume Share, By Virus Type, 2021 & 2031F |
3.6 United Kingdom (UK) Herpes Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 United Kingdom (UK) Herpes Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 United Kingdom (UK) Herpes Market Revenues & Volume Share, By Age, 2021 & 2031F |
3.9 United Kingdom (UK) Herpes Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.10 United Kingdom (UK) Herpes Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.11 United Kingdom (UK) Herpes Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 United Kingdom (UK) Herpes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and education about herpes in the UK |
4.2.2 Rising prevalence of herpes infections in the UK population |
4.2.3 Technological advancements in herpes diagnosis and treatment |
4.3 Market Restraints |
4.3.1 Stigma associated with herpes leading to underreporting and misdiagnosis |
4.3.2 Limited access to affordable herpes treatment options |
4.3.3 Regulatory challenges in the approval process for new herpes treatments |
5 United Kingdom (UK) Herpes Market Trends |
6 United Kingdom (UK) Herpes Market, By Types |
6.1 United Kingdom (UK) Herpes Market, By Virus Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Herpes Market Revenues & Volume, By Virus Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Herpes Market Revenues & Volume, By Herpes Simplex, 2021- 2031F |
6.1.4 United Kingdom (UK) Herpes Market Revenues & Volume, By Herpes Zoster, 2021- 2031F |
6.2 United Kingdom (UK) Herpes Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Herpes Market Revenues & Volume, By Acyclovir, 2021- 2031F |
6.2.3 United Kingdom (UK) Herpes Market Revenues & Volume, By Docosanol, 2021- 2031F |
6.2.4 United Kingdom (UK) Herpes Market Revenues & Volume, By Valacyclovir, 2021- 2031F |
6.2.5 United Kingdom (UK) Herpes Market Revenues & Volume, By Famciclovir, 2021- 2031F |
6.2.6 United Kingdom (UK) Herpes Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Herpes Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Herpes Market Revenues & Volume, By Prescription Drug, 2021- 2031F |
6.3.3 United Kingdom (UK) Herpes Market Revenues & Volume, By Over-the-counter Drug, 2021- 2031F |
6.4 United Kingdom (UK) Herpes Market, By Age |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Herpes Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.3 United Kingdom (UK) Herpes Market Revenues & Volume, By Pediatrics, 2021- 2031F |
6.5 United Kingdom (UK) Herpes Market, By Route Of Administration |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Herpes Market Revenues & Volume, By Topical, 2021- 2031F |
6.5.3 United Kingdom (UK) Herpes Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.4 United Kingdom (UK) Herpes Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.6 United Kingdom (UK) Herpes Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Herpes Market Revenues & Volume, By Hospitals Pharmacies, 2021- 2031F |
6.6.3 United Kingdom (UK) Herpes Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.6.4 United Kingdom (UK) Herpes Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.6.5 United Kingdom (UK) Herpes Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6.6 United Kingdom (UK) Herpes Market Revenues & Volume, By Others, 2021- 2031F |
6.7 United Kingdom (UK) Herpes Market, By End Users |
6.7.1 Overview and Analysis |
6.7.2 United Kingdom (UK) Herpes Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 United Kingdom (UK) Herpes Market Revenues & Volume, By Speciality Clinics, 2021- 2031F |
6.7.4 United Kingdom (UK) Herpes Market Revenues & Volume, By , 2021- 2031F |
7 United Kingdom (UK) Herpes Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Herpes Market Export to Major Countries |
7.2 United Kingdom (UK) Herpes Market Imports from Major Countries |
8 United Kingdom (UK) Herpes Market Key Performance Indicators |
8.1 Number of herpes awareness campaigns conducted in the UK |
8.2 Percentage of herpes cases diagnosed accurately in the UK |
8.3 Adoption rate of new herpes treatment technologies in the UK |
9 United Kingdom (UK) Herpes Market - Opportunity Assessment |
9.1 United Kingdom (UK) Herpes Market Opportunity Assessment, By Virus Type, 2021 & 2031F |
9.2 United Kingdom (UK) Herpes Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 United Kingdom (UK) Herpes Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 United Kingdom (UK) Herpes Market Opportunity Assessment, By Age, 2021 & 2031F |
9.5 United Kingdom (UK) Herpes Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
9.6 United Kingdom (UK) Herpes Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.7 United Kingdom (UK) Herpes Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 United Kingdom (UK) Herpes Market - Competitive Landscape |
10.1 United Kingdom (UK) Herpes Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Herpes Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here